Key Highlights

  • Exascale Labs (NASDAQ:XLAB) traded at USD 2.78 in intraday trading on November 13, 2026, up 22.47%, on about 13.2 million shares against a three-month average of roughly 6.68 million.
  • No new release was issued on November 13; the latest disclosure is a November 9 filing of a firm order for 16 GPU servers built on NVIDIA HGX B300 systems, at USD 565,000 each or USD 9.04 million in total.
  • Two Supply frameworks allow purchases of up to 128 servers worth up to USD 72.32 million through March 31, 2027, with no minimum commitment.
  • Fiscal 2026 Revenue rose 111.3% to USD 14.8 million, while the net loss widened to USD 12.2 million and a resale registration covers up to 12.25 million Class A shares.

A Rebound After the Server Order Selloff

Exascale Labs provides GPU compute capacity and AI-ready data centre infrastructure on an asset-light model, combining cluster management software with modular data centres. On November 9 it disclosed a firm order with a Taiwanese contract manufacturer for 16 GPU servers built on NVIDIA HGX B300 platforms, priced at USD 565,000 each for a total of USD 9.04 million. It must pay a 20% deposit of USD 1.81 million within five Business days of confirmation and the remaining USD 7.23 million before shipment, with servers ready four to six weeks after the deposit. A separate order for 12 similar servers worth USD 8.21 million was disclosed in a resale prospectus. The stock fell 25.33% on November 9, as investors focused on how the purchases would be funded alongside the resale registration filed the same day. No release explained the November 13 rise, which looks like a rebound in a stock that is closely tied to sentiment around AI infrastructure, where Demand for the newest NVIDIA systems remains strong.

Growth Is Real but Losses Are Widening

The company's fiscal year ends on June 30. For fiscal 2026 revenue rose 111.3% to USD 14.8 million and Gross Profit was USD 2.4 million, a Margin of roughly 16%. Operating expenses rose to USD 7.2 million from USD 4.2 million, and the net loss widened to USD 12.2 million from USD 7.7 million, taking the accumulated Deficit to USD 25.4 million. Cash was USD 2.7 million at June 30, before roughly USD 11.8 million of net proceeds from the business combination with a special purpose Acquisition company that closed on August 27, after which the shares and warrants began trading. The company cites a pipeline of about USD 300 million and plans to expand capacity and monetise its software in fiscal 2027. Server orders of about USD 17 million combined are larger than the cash it reported after the merger, so financing for the balance due before shipment, or customer prepayments, will be important.

Share Supply and Valuation Questions

Supply of shares is the main overhang. A resale prospectus covers up to 12.25 million Class A shares and 100,000 Warrant shares held by existing investors, and the company receives no proceeds from those sales. As of November 4 there were about 33.7 million Class A and 30.6 million Class B shares outstanding. Public warrants with a USD 11.50 exercise price trade separately but are far out of the money. At USD 2.78 the intraday Market Value is about USD 173.7 million, roughly 12 times trailing revenue, which prices in strong growth for a business that is still losing money and has limited cash. The stock remains well below its 52-week high of USD 11.17. Investors should watch how the server deposits and balance payments are funded, whether customer contracts are signed for the new capacity and how much of the registered stock is sold into the market.

Where Things Stand

Exascale Labs (NASDAQ:XLAB) rose 22.47% to USD 2.78 on November 13, 2026, rebounding after a selloff that followed its USD 9.04 million GPU server order. Revenue more than doubled last fiscal year, but widening losses, limited cash and up to 12.25 million shares registered for resale keep funding the central question.